Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Politano

Showing results (591-600 of 638) with videos related to

Pageof 64
Sort By:
Annals of Internal Medicine|September 3, 2019
Cardiac and Neuromuscular Features of Patients With LMNA-Related CardiomyopathyGiovanni Peretto, Chiara Di Resta, Jacopo Perversi, et al.
Neuromuscular Disorders : NMD|January 21, 2014
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophyMarika Pane, Elena S Mazzone, Lavinia Fanelli, et al.
Plos One|October 2, 2014
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changesMarika Pane, Elena Stacy Mazzone, Serena Sivo, et al.
Drugs in R&D|May 28, 2025
Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular DystrophyLuca Bello, Pietro Riguzzi, Emilio Albamonte, et al.
Plos One|March 17, 2016
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational StudyElena S Mazzone, Giorgia Coratti, Maria Pia Sormani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3Lorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Muscle & Nerve|August 3, 2024
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersenAlessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Journal of Neuromuscular Diseases|April 17, 2023
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?Marika Pane, Giorgia Coratti, Claudia Brogna, et al.
JAMA Neurology|February 14, 2018
Interpreting Genetic Variants in Titin in Patients With Muscle DisordersMarco Savarese, Lorenzo Maggi, Anna Vihola, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2022
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on diseaseLorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Pageof 64

Showing results (591-600 of 638) with videos related to

Sort By:
Pageof 64
Annals of Internal Medicine|September 3, 2019
Cardiac and Neuromuscular Features of Patients With LMNA-Related CardiomyopathyGiovanni Peretto, Chiara Di Resta, Jacopo Perversi, et al.
Neuromuscular Disorders : NMD|January 21, 2014
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophyMarika Pane, Elena S Mazzone, Lavinia Fanelli, et al.
Plos One|October 2, 2014
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changesMarika Pane, Elena Stacy Mazzone, Serena Sivo, et al.
Drugs in R&D|May 28, 2025
Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular DystrophyLuca Bello, Pietro Riguzzi, Emilio Albamonte, et al.
Plos One|March 17, 2016
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational StudyElena S Mazzone, Giorgia Coratti, Maria Pia Sormani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3Lorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Muscle & Nerve|August 3, 2024
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersenAlessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Journal of Neuromuscular Diseases|April 17, 2023
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?Marika Pane, Giorgia Coratti, Claudia Brogna, et al.
JAMA Neurology|February 14, 2018
Interpreting Genetic Variants in Titin in Patients With Muscle DisordersMarco Savarese, Lorenzo Maggi, Anna Vihola, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2022
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on diseaseLorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Pageof 64